Synlett 2012; 23(12): 1832-1834
DOI: 10.1055/s-0031-1290407
letter
© Georg Thieme Verlag Stuttgart · New York

Asymmetric Total Synthesis of ent-Tetrahydrolipstatin from an Epoxy Alkenol

Hyemi Kim
Department of Chemistry, Yonsei University, Seoul 120-749, Korea, Fax: +82(2)3647050   Email: jstae@yonsei.ac.kr
,
Kyeonghwan Choi
Department of Chemistry, Yonsei University, Seoul 120-749, Korea, Fax: +82(2)3647050   Email: jstae@yonsei.ac.kr
,
Jinsung Tae*
Department of Chemistry, Yonsei University, Seoul 120-749, Korea, Fax: +82(2)3647050   Email: jstae@yonsei.ac.kr
› Author Affiliations
Further Information

Publication History

Received: 12 April 2012

Accepted after revision: 07 May 2012

Publication Date:
04 July 2012 (online)


Abstract

A highly efficient asymmetric total synthesis of ent-­tetrahydrolipstatin (THL) was accomplished from the known epoxy alkenol. The β-lactone portion of THL was synthesized by the epoxide opening with cyanide and stereoselective enolate alkylation method. The side chain was introduced by cross metathesis of the alkene part with 1-decene. Coupling with a protected leucine completed the synthesis of ent-tetrahydrolipstatin.

Supporting Information

 
  • References and Notes

    • 1a Weibel EK, Hadvary P, Hochuli E, Kupfer E, Lengsfeld H. J. Antibiot. 1987; 40: 1081
    • 1b Hochuli E, Kupfer R, Maurer R, Meister W, Mercadal Y, Schmidt K. J. Antibiot. 1987; 40: 1086
  • 2 Hadvary P, Sidler W, Meister W, Vetter W, Wolfer H. J. Biol. Chem. 1991; 266: 2021
  • 3 Hogan S, Fleury A, Hadvary P, Lengsfeld H, Meier MK, Triscari J, Sullivan AC. Int. J. Obes. 1987; 11 (Suppl. 03) 35
    • 4a Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW. Cancer Res. 2004; 64: 2070
    • 4b Knowles LM, Axelrod F, Browne CD, Smith JW. J. Biol. Chem. 2004; 279: 30540
    • 4c Little JL, Wheeler FB, Fels DR, Koumenis C, Kridel SJ. Cancer Res. 2007; 67: 1262
    • 4d Pemble CW, Johnson LC, Kridel SJ, Lowther WT. Nat. Struct. Mol. Biol. 2007; 14: 704
    • 4e Yang P.-Y, Liu K, Ngai MH, Lear MJ, Wenk MR, Yao SQ. J. Am. Chem. Soc. 2010; 132: 656
    • 5a Barbier P, Schneider F. Helv. Chim. Acta 1987; 70: 196
    • 5b Barbier P, Schneider F, Widmer U. Helv. Chim. Acta 1987; 70: 1412
    • 6a Barbier P, Schneider F. J. Org. Chem. 1988; 53: 1218
    • 6b Pons J.-M, Kocienski P. Tetrahedron Lett. 1989; 30: 1833
    • 6c Fleming I, Lawrence NJ. Tetrahedron Lett. 1990; 31: 3645
    • 6d Case-Green SC, Davies SG, Hedgecock CJ. R. Synlett 1991; 781
    • 6e Chadha NK, Batcho AD, Tang PC, Courtney LF, Cook CM, Wovkulich PM, Uskokovic MR. J. Org. Chem. 1991; 56: 4714
    • 6f Hanessian S, Tehim A, Chen P. J. Org. Chem. 1993; 58: 7768
    • 6g Paterson I, Doughty VA. Tetrahedron Lett. 1999; 40: 393
    • 6h Ghosh AK, Liu C. Chem. Commun. 1999; 1743
    • 6i Bodkin JA, Humphries EJ, McLeod MD. Tetrahedron Lett. 2003; 44: 2869
    • 6j Thadani AN, Batey RA. Tetrahedron Lett. 2003; 44: 8051
    • 6k Polkowska J, Łukaszewicz E, Kiegiel J, Jurczak J. Tetrahedron Lett. 2004; 45: 3873
    • 6l Ma G, Zancanella M, Oyola Y, Richardson RD, Smith JW, Romo D. Org. Lett. 2006; 8: 4497
    • 6m Yadav JS, Rao KV, Prasad AR. Synthesis 2006; 3888
    • 6n Yadav JS, Rao KV, Reddy MS, Prasad AR. Tetrahedron Lett. 2006; 47: 4393
    • 6o Yadav JS, Reddy MS, Prasad AR. Tetrahedron Lett. 2006; 47: 4995
    • 6p Case-Green SC, Davies SG, Roberts PM, Russell AJ, Thomson JE. Tetrahedron: Asymmetry 2008; 19: 2620
    • 6q Kumaraswamy G, Markondaiah B. Tetrahedron Lett. 2008; 49: 327
    • 6r Ghosh AK, Shurrush K, Kulkarni S. J. Org. Chem. 2009; 74: 4508
    • 6s Raghavan S, Rathore K. Synlett 2009; 1285
    • 6t Raghaven S, Rathore K. Tetrahedron 2009; 65: 10083
    • 6u Venukadasula PK. M, Chegondi R, Maitra S, Hanson PR. Org. Lett. 2010; 12: 1556
    • 6v Aubry S, Aubert G, Cresteil T, Crich D. Org. Biomol. Chem. 2012; 10: 2629
    • 7a Kim Y.-J, Tae J. Synlett 2006; 61
    • 7b Lee J, Jung Y.-H, Tae J. Bull. Korean Chem. Soc. 2007; 28: 513
    • 7c Jung Y.-H, Lee J, Tae J. Chem.–Asian J. 2007; 2: 656
    • 7d Kim M.-Y, Kim H, Tae J. Synlett 2009; 1303
    • 7e Kim H, Kim M.-Y, Tae J. Synlett 2009; 2949
  • 8 Fujimoto K, Iwano Y, Hirai K. Tetrahedron Lett. 1985; 26: 89
    • 9a Bruson HA. Org. React. 1949; 5: 79
    • 9b Vaughn HL, Robbins MD. J. Org. Chem. 1975; 40: 1187
    • 9c Huhtasaari M, Schäfer HJ, Becking L. Angew. Chem., Int. Ed. Engl. 1984; 23: 980
    • 9d McCarroll AJ, Walton JC. J. Chem. Soc., Perkin Trans. 2 2000; 2399
  • 10 Fráter G, Müller U, Günther W. Tetrahedron 1984; 40: 1269
  • 11 We could not detect the minor diastereomer by 1H NMR spectroscopy or HPLC analysis
    • 12a Tung RD, Rich DH. J. Am. Chem. Soc. 1985; 107: 4342
    • 12b Colucci WJ, Tung RD, Petri JA, Rich DH. J. Org. Chem. 1990; 55: 2895
  • 13 Mulzer J, Kerkmann T. J. Am. Chem. Soc. 1980; 102: 3620
  • 14 Spectral Data for ent-Tetrahydrolipstatin (1) Rf = 0.32 (silica gel, hexane–EtOAc = 7:3); [α]D 20 +30.66 (c 0.36, CHCl3); mp 41–42 °C. 1H NMR (400 MHz, CDCl3): δ = 8.22 (s, 1 H), 5.93 (d, J = 8.0 Hz, 1 H), 5.04–5.02 (m, 1 H), 4.71–4.67 (m, 1 H), 4.31–4.27 (m, 1 H), 3.23–3.21 (m, 1 H), 2.19–2.15 (m, 1 H), 2.03–1.98 (m, 1 H), 1.87–1.54 (m, 7 H), 1.29–1.25 (m, 26 H), 0.98–0.94 (m. 6 H), 0.90–0.86 (m, 6 H). 13C NMR (100.6 MHz, CDCl3): δ = 172.1, 170.9, 160.8, 74.9, 72.9, 57.2, 49.8, 41.7, 38.9, 34.2, 32.1, 31.6, 29.8, 29.7, 29.6, 29.5, 29.1, 27.8, 26.9, 25.2, 25.1, 23.0, 22.8, 22.7, 21.9, 14.3, 14.2. IR (film): 3353, 3025, 2954, 2924, 2855, 1825, 1733, 1699, 1652, 1521, 1456, 1386, 1273, 1250, 1195, 1126, 877, 815, 761 cm–1. HRMS: m/z calcd for C29H54NO5[M + H]+: 496.4002; found: 496.4004